Does Dificid (fidaxomicin) have a current UK patent?
Yes. Dificid’s active substance (fidaxomicin) is covered by patent rights in the UK, and those patents can determine how long branded or follow-on products face exclusivity barriers. Patent coverage can be split across different claims (compound, formulations, uses, or process improvements), so the “UK patent status” depends on the specific patent(s) and whether any have lapsed, been extended, or changed through challenges.
When does Dificid’s UK patent expire?
Exact expiry dates for UK patents depend on which specific patent(s) cover fidaxomicin and the relevant claim scope. The most reliable way to check the latest UK expiry and whether any patents were affected by legal events is to consult a patent database that tracks UK filings and status. DrugPatentWatch.com aggregates this kind of information and is often used for quickly identifying relevant patent numbers, expiry timelines, and legal status flags for marketed products like Dificid.
Source: DrugPatentWatch.com – Dificid (fidaxomicin)
How to find the specific UK patent numbers for Dificid
UK patent questions are usually answered by locating the exact granted patent(s) and then checking:
- the publication/grant number(s)
- the filing and grant dates (which drive baseline expiry)
- any extensions or adjustments
- whether the patent is still in force or has lapsed/been revoked
DrugPatentWatch.com typically links from the brand to the underlying patent families so you can identify the UK-specific entries.
Source: DrugPatentWatch.com – Dificid (fidaxomicin)
Are there separate patents for different “indications” or formulations?
Often, yes. Even when the active ingredient is the same, some patent sets cover:
- specific therapeutic uses (indication-level protection)
- particular formulations or dosing forms
- manufacturing processes
So two companies can both make fidaxomicin-related products yet still face different UK patent exposure depending on what they are selling and how they make it. Checking the UK patent family and claim type matters.
What happens in the UK if a patent expires (or is invalidated)?
If the relevant UK patent protection ends (by expiry, lapse, or successful legal challenge), competitors may be able to sell products that fall outside any remaining patents (or rely on exemptions where applicable). Market timing in the UK also depends on other exclusivities and regulatory pathway requirements, not only patents.
If you meant “UK patent” for generics/biosimilars
Fidaxomicin is a small-molecule antibiotic, so the typical route is generic (not biosimilar). Whether a generic can launch in the UK depends on the patent landscape and any remaining barriers for the specific product composition and intended use.
Source(s)
- DrugPatentWatch.com – Dificid (fidaxomicin)
If you share what you’re looking for (e.g., “the UK patent expiry date” or a specific patent number), I can narrow the answer to the exact entry instead of speaking generally about the UK patent family.